Jeremy Grantham Moderna, Inc. Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $9 Million - $12.2 Million	-105,366 Reduced 25.58%	306,480 $32.7 Million
Q4 2023 Feb 13, 2024	BUY	$69.51 - $104.43 $7.33 Million - $11 Million	105,431 Added 34.41%	411,846 $41 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $4.96 Million - $6.52 Million	51,474 Added 20.19%	306,415 $31.6 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $12.2 Million - $16.6 Million	103,141 Added 67.95%	254,941 $31 Million
Q1 2023 May 12, 2023	BUY	$135.66 - $197.02 $20.6 Million - $29.9 Million	151,800 New	151,800 $23.3 Million

1,112

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $23.6B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.